Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,802 | 36,968 | 135,158 | 111,131 | 190,335 |
| Marketable Securities | 229,696 | 94,965 | 62,698 | 73,783 | N/A |
| Receivables | 1,737 | 3,117 | 4,853 | 2,541 | 5,839 |
| TOTAL | $278,192 | $137,254 | $209,626 | $192,813 | $204,126 |
| Non-Current Assets | |||||
| PPE Net | 312 | 413 | 651 | 1,081 | 1,448 |
| Intangibles | 0 | 0 | 0 | 12,419 | 12,419 |
| Other Non-Current Assets | 1,425 | 1,639 | 363 | 615 | 872 |
| TOTAL | $1,737 | $2,052 | $1,014 | $14,115 | $14,739 |
| Total Assets | $279,929 | $139,306 | $210,640 | $206,928 | $218,865 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,717 | 211 | 2,070 | 4,804 | 2,034 |
| Accrued Expenses | 12,280 | 10,257 | 10,073 | 12,250 | 10,152 |
| Other current liabilities | N/A | N/A | N/A | N/A | 6,090 |
| TOTAL | $14,997 | $10,468 | $12,143 | $17,054 | $18,276 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,287 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 5,753 | 5,330 | 4,398 | 4,581 | 1,454 |
| TOTAL | $40,040 | $5,330 | $4,398 | $4,581 | $1,454 |
| Total Liabilities | $55,037 | $15,798 | $16,541 | $21,635 | $19,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,070 | 77,014 | 70,895 | 49,279 | 43,223 |
| Common Shares | 11 | 7 | 7 | 5 | 4 |
| Retained earnings | -649,483 | -561,390 | -466,331 | -377,884 | -293,171 |
| Other shareholders' equity | -4,928 | -4,973 | -5,004 | -5,227 | -5,040 |
| TOTAL | $224,892 | $123,508 | $194,099 | $185,293 | $199,135 |
| Total Liabilities And Equity | $279,929 | $139,306 | $210,640 | $206,928 | $218,865 |